Lista de obras - Paolo Gandellini - Dominio Público Uruguay

Anti-tumor activity of selective inhibitors of XPO1/CRM1-mediated nuclear export in diffuse malignant peritoneal mesothelioma: the role of survivin.

artículo científico publicado en 2015

Antisense oligonucleotide-mediated inhibition of hTERT, but not hTERC, induces rapid cell growth decline and apoptosis in the absence of telomere shortening in human prostate cancer cells.

artículo científico publicado en 2005

Antitumor activity of miR-34a in peritoneal mesothelioma relies on c-MET and AXL inhibition: persistent activation of ERK and AKT signaling as a possible cytoprotective mechanism

artículo científico publicado en 2017

Apollon gene silencing induces apoptosis in breast cancer cells through p53 stabilisation and caspase-3 activation

artículo científico publicado en 2009

Clusterin: a potential target for improving response to antiestrogens.

artículo científico publicado en 2008

Coated cationic lipid-nanoparticles entrapping miR-660 inhibit tumor growth in patient-derived xenografts lung cancer models

scientific article published on 09 July 2019

Coding the noncoding: 2 years of advances in the field of microRNAs and long noncoding RNAs

artículo científico publicado en 2020

Complexity in the tumour microenvironment: Cancer associated fibroblast gene expression patterns identify both common and unique features of tumour-stroma crosstalk across cancer types

artículo científico

Core Biopsies from Prostate Cancer Patients in Active Surveillance Protocols Harbor PTEN and MYC Alterations

scientific article published on 10 September 2018

Dissecting the role of microRNAs in prostate cancer metastasis: implications for the design of novel therapeutic approaches

artículo científico publicado en 2016

Down-regulation of human telomerase reverse transcriptase through specific activation of RNAi pathway quickly results in cancer cell growth impairment

scientific article published on 01 February 2007

Emerging role of microRNAs in prostate cancer: implications for personalized medicine.

artículo científico publicado en 2010

Gene expression dataset of prostate cells upon MIR205HG/LEADR modulation

artículo científico publicado en 2020

Integrated gene and miRNA expression analysis of prostate cancer associated fibroblasts supports a prominent role for interleukin-6 in fibroblast activation

artículo científico publicado en 2015

LEADeR role of miR-205 host gene as long noncoding RNA in prostate basal cell differentiation

artículo científico publicado en 2019

Large oncosomes mediate intercellular transfer of functional microRNA.

artículo científico publicado en 2013

Mesenchymal to amoeboid transition is associated with stem-like features of melanoma cells

artículo científico publicado en 2014

MicroRNA-Mediated Control of Prostate Cancer Metastasis: Implications for the Identification of Novel Biomarkers and Therapeutic Targets ⬇️

artículo científico publicado el 1 de enero de 2013

MicroRNA-dependent regulation of telomere maintenance mechanisms: a field as much unexplored as potentially promising.

artículo científico

MicroRNAs and the Response of Prostate Cancer to Anti-Cancer Drugs

artículo científico

MicroRNAs as new therapeutic targets and tools in cancer.

artículo científico publicado en 2011

MicroRNAs in Cancer Management: Big Challenges for Small Molecules.

artículo científico publicado en 2015

MicroRNAs: Cobblestones on the Road to Cancer Metastasis ⬇️

artículo científico publicado el 1 de enero de 2013

Oligomer-mediated modulation of hTERT alternative splicing induces telomerase inhibition and cell growth decline in human prostate cancer cells.

artículo científico publicado en 2004

PKC-alpha modulation by miR-483-3p in platinum-resistant ovarian carcinoma cells

artículo científico publicado en 2016

Photochemically enhanced delivery of a cell-penetrating peptide nucleic acid conjugate targeting human telomerase reverse transcriptase: effects on telomere status and proliferative potential of human prostate cancer cells.

artículo científico publicado en 2007

Predicting and Understanding Cancer Response to Treatment

artículo científico publicado en 2018

RNA interference-mediated validation of survivin and Apollon/BRUCE as new therapeutic targets for cancer therapy.

artículo científico publicado en 2012

Reciprocal metabolic reprogramming through lactate shuttle coordinately influences tumor-stroma interplay

artículo científico publicado en 2012

SPOP Deregulation Improves the Radiation Response of Prostate Cancer Models by Impairing DNA Damage Repair

scientific article published on 04 June 2020

Senescent stroma promotes prostate cancer progression: the role of miR-210.

artículo científico publicado en 2014

Splicing modulation as novel therapeutic strategy against diffuse malignant peritoneal mesothelioma

artículo científico publicado en 2018

Targeting microRNAs to withstand cancer metastasis

artículo científico publicado en 2015

Towards the definition of prostate cancer-related microRNAs: where are we now?

artículo científico publicado en 2009

Unveiling the ups and downs of miR-205 in physiology and cancer: transcriptional and post-transcriptional mechanisms

scientific article published on 15 November 2020

miR-1272 Exerts Tumor-Suppressive Functions in Prostate Cancer via HIP1 Suppression

scientific article published on 13 February 2020

miR-205 Exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase Cepsilon.

artículo científico publicado en 2009

miR-205 enhances radiation sensitivity of prostate cancer cells by impairing DNA damage repair through PKCε and ZEB1 inhibition

artículo científico publicado en 2019

miR-205 hinders the malignant interplay between prostate cancer cells and associated fibroblasts

artículo científico publicado en 2013

miR-205 impairs the autophagic flux and enhances cisplatin cytotoxicity in castration-resistant prostate cancer cells

artículo científico publicado en 2013

miR-21: an oncomir on strike in prostate cancer.

artículo científico publicado en 2010

miR-380-5p-mediated repression of TEP1 and TSPYL5 interferes with telomerase activity and favours the emergence of an "ALT-like" phenotype in diffuse malignant peritoneal mesothelioma cells

artículo científico publicado en 2017

miR-875-5p counteracts epithelial-to-mesenchymal transition and enhances radiation response in prostate cancer through repression of the EGFR-ZEB1 axis

artículo científico publicado en 2017

miRNAs in tumor radiation response: bystanders or participants?

artículo científico publicado en 2014

microRNAs as players and signals in the metastatic cascade: Implications for the development of novel anti-metastatic therapies.

artículo científico publicado en 2017

Lista de obras de Paolo Gandellini

Anti-tumor activity of selective inhibitors of XPO1/CRM1-mediated nuclear export in diffuse malignant peritoneal mesothelioma: the role of survivin.

Antisense oligonucleotide-mediated inhibition of hTERT, but not hTERC, induces rapid cell growth decline and apoptosis in the absence of telomere shortening in human prostate cancer cells.

Antitumor activity of miR-34a in peritoneal mesothelioma relies on c-MET and AXL inhibition: persistent activation of ERK and AKT signaling as a possible cytoprotective mechanism

Apollon gene silencing induces apoptosis in breast cancer cells through p53 stabilisation and caspase-3 activation

Clusterin: a potential target for improving response to antiestrogens.

Coated cationic lipid-nanoparticles entrapping miR-660 inhibit tumor growth in patient-derived xenografts lung cancer models

Coding the noncoding: 2 years of advances in the field of microRNAs and long noncoding RNAs

Complexity in the tumour microenvironment: Cancer associated fibroblast gene expression patterns identify both common and unique features of tumour-stroma crosstalk across cancer types

Core Biopsies from Prostate Cancer Patients in Active Surveillance Protocols Harbor PTEN and MYC Alterations

Dissecting the role of microRNAs in prostate cancer metastasis: implications for the design of novel therapeutic approaches

Down-regulation of human telomerase reverse transcriptase through specific activation of RNAi pathway quickly results in cancer cell growth impairment

Emerging role of microRNAs in prostate cancer: implications for personalized medicine.

Gene expression dataset of prostate cells upon MIR205HG/LEADR modulation

Integrated gene and miRNA expression analysis of prostate cancer associated fibroblasts supports a prominent role for interleukin-6 in fibroblast activation

LEADeR role of miR-205 host gene as long noncoding RNA in prostate basal cell differentiation

Large oncosomes mediate intercellular transfer of functional microRNA.

Mesenchymal to amoeboid transition is associated with stem-like features of melanoma cells

MicroRNA-Mediated Control of Prostate Cancer Metastasis: Implications for the Identification of Novel Biomarkers and Therapeutic Targets ⬇️

MicroRNA-dependent regulation of telomere maintenance mechanisms: a field as much unexplored as potentially promising.

MicroRNAs and the Response of Prostate Cancer to Anti-Cancer Drugs

MicroRNAs as new therapeutic targets and tools in cancer.

MicroRNAs in Cancer Management: Big Challenges for Small Molecules.

MicroRNAs: Cobblestones on the Road to Cancer Metastasis ⬇️

Oligomer-mediated modulation of hTERT alternative splicing induces telomerase inhibition and cell growth decline in human prostate cancer cells.

PKC-alpha modulation by miR-483-3p in platinum-resistant ovarian carcinoma cells

Photochemically enhanced delivery of a cell-penetrating peptide nucleic acid conjugate targeting human telomerase reverse transcriptase: effects on telomere status and proliferative potential of human prostate cancer cells.

Predicting and Understanding Cancer Response to Treatment

RNA interference-mediated validation of survivin and Apollon/BRUCE as new therapeutic targets for cancer therapy.

Reciprocal metabolic reprogramming through lactate shuttle coordinately influences tumor-stroma interplay

SPOP Deregulation Improves the Radiation Response of Prostate Cancer Models by Impairing DNA Damage Repair

Senescent stroma promotes prostate cancer progression: the role of miR-210.

Splicing modulation as novel therapeutic strategy against diffuse malignant peritoneal mesothelioma

Targeting microRNAs to withstand cancer metastasis

Towards the definition of prostate cancer-related microRNAs: where are we now?

Unveiling the ups and downs of miR-205 in physiology and cancer: transcriptional and post-transcriptional mechanisms

miR-1272 Exerts Tumor-Suppressive Functions in Prostate Cancer via HIP1 Suppression

miR-205 Exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase Cepsilon.

miR-205 enhances radiation sensitivity of prostate cancer cells by impairing DNA damage repair through PKCε and ZEB1 inhibition

miR-205 hinders the malignant interplay between prostate cancer cells and associated fibroblasts

miR-205 impairs the autophagic flux and enhances cisplatin cytotoxicity in castration-resistant prostate cancer cells

miR-21: an oncomir on strike in prostate cancer.

miR-380-5p-mediated repression of TEP1 and TSPYL5 interferes with telomerase activity and favours the emergence of an "ALT-like" phenotype in diffuse malignant peritoneal mesothelioma cells

miR-875-5p counteracts epithelial-to-mesenchymal transition and enhances radiation response in prostate cancer through repression of the EGFR-ZEB1 axis

miRNAs in tumor radiation response: bystanders or participants?

microRNAs as players and signals in the metastatic cascade: Implications for the development of novel anti-metastatic therapies.